N@N

GBCI, FDS, GENZ, HOG, MEI, CHSI Are Seasonally Ripe To Go Up In the Next Five Weeks

June 14, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of GLACIER BANCORP INC (NASDAQ:GBCI), FACTSET RESEARCH SYSTEMS INC (NYSE:FDS), GENZYME CORP (NASDAQ:GENZ), HARLEY-DAVIDSON INC (NYSE:HOG), METHODE ELECTRONICS INC (NYSE:MEI), CATALYST HEALTH SOLUTIONS IN (NASDAQ:CHSI) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Up:

     Symbol     Company                             Expected Return     Odds                    By The Following Date
     GBCI       GLACIER BANCORP INC                 5.54%               70.83% (17 of 24)       Wednesday, July 27th 2011
     FDS        FACTSET RESEARCH SYSTEMS INC        5.92%               78.57% (11 of 14)       Tuesday, June 28th 2011
     GENZ       GENZYME CORP                        6.96%               60.00% (15 of 25)       Wednesday, July 27th 2011
     HOG        HARLEY-DAVIDSON INC                 6.79%               75.00% (18 of 24)       Wednesday, July 27th 2011
     MEI        METHODE ELECTRONICS INC             5.73%               68.00% (17 of 25)       Monday, July 11th 2011
     CHSI       CATALYST HEALTH SOLUTIONS IN        7.50%               72.73% (8 of 11)        Wednesday, July 6th 2011

GLACIER BANCORP INC (NASDAQ:GBCI) - Glacier Bancorp, Inc., a multi-bank holding company, provides commercial banking products and services in Montana, Idaho, Wyoming, Colorado, Utah, and Washington. It generates various deposit products, including regular statement savings, interest-bearing checking, money market deposit, fixed rate certificates of deposit, negotiated-rate jumbo certificates, non-interest demand, and individual retirement accounts, as well as wholesale deposits comprising the certificate of deposit account registry system. The companys lending activities consist of the origination of both construction and permanent loans on residential real estate loans, as well as the provision of residential mortgage loans and interim construction financing for single-family dwellings; land acquisition and development loans on properties intended for residential and commercial use; pre-sold and spec-home construction and lot acquisition loans; commercial real estate loans to purchase, construct, and finance commercial real estate properties; consumer loans secured by real estate, automobiles, and other assets; and second mortgage and home equity loans. It also offers mortgage origination services and retail brokerage services. Glacier Bancorp serves individuals, small to medium-sized businesses, community organizations, and public entities. As of December 31, 2009, it operated 106 banking offices. Glacier Bancorp, Inc. was founded in 1955 and is headquartered in Kalispell, Montana.

FACTSET RESEARCH SYSTEMS INC (NYSE:FDS) - FactSet Research Systems Inc. provides financial and economic information to investment community worldwide. FactSet offers fundamental financial data on various companies, analytical applications, and client services to the portfolio managers, research and performance analysts, risk managers, marketing professionals, sell-side equity research professionals, investment bankers, and fixed income professionals. The companys applications provide users access to company analysis, multicompany comparisons, industry analysis, company screening, portfolio analysis, predictive risk measurements, alphatesting, portfolio optimization and simulation, news and quotes, and tools to value and analyze fixed income securities and portfolios. FactSet combines commercial databases, including content regarding companies and securities from various markets into a single online platform of information and analytics. The companys solutions for investment management professionals include analyzing market, sector, and fundamental series; offering applications for portfolio attribution, risk management, and quantitative analysis; building quant models and calculating risk; analyzing the nuances of the debt-driven market; viewing event transcripts and corporate event calendars; researching and analyzing companies, benchmarks, debt instruments, and economic series; integrating the clients own data, such as portfolio holdings and research notes; and creating reports and presentations. FactSets solutions for investment banking professionals comprise creating models and presentations; tracking market performance and headlines; providing deal analytic and corporate governance servies; researching on public and private companies; auditing financials underlying SEC filings and annual reports; and providing access to reports via wireless handheld device. The company was founded in 1978 and is headquartered in Norwalk, Connecticut.

GENZYME CORP (NASDAQ:GENZ) - Genzyme Corporation operates as a biotechnology company worldwide. It focuses on rare genetic disease disorders, renal diseases, orthopaedics, cancers, transplant and immune diseases, and diagnostic and predictive testing areas. The companys Genetic Diseases segment manufactures and distributes Cerezyme for the treatment of Gaucher disease; Fabrazyme for the treatment of Fabry disease; Myozyme for the treatment of Pompe disease; Aldurazyme for the treatment of Mucopolysaccharidosis I; and Elaprase for the treatment of Mucopolysaccharidosis II. Its Cardiometabolic and Renal segment offers Renagel and Renvela for the control of serum phosphorus in patients with chronic kidney disease on dialysis; Hectorol for the treatment of secondary hyperparathyroidism; and Thyrogen, an adjunctive diagnostic agent used in the follow-up of patients with well-differentiated thyroid cancer. The companys Biosurgery segment provides Synvisc, a biomaterial-based product that is used to treat the pain associated with osteoarthritis of the knee; and Sepra family of products to prevent adhesions following various surgical procedures in the abdomen and pelvis. Its Hematologic Oncology segment develops products for the treatment of cancer, including Campath and Fludara for the treatment of leukemia and lymphoma; Clolar for the treatment of acute leukemia; Leukine for the reduction of the incidence of severe and life-threatening infections in older adult patients with AML following chemotherapy and certain other uses; and Mozobil for the mobilization of hematopoietic stem cells. The company has strategic alliances with Bayer; Osiris Therapeutics, Inc.; PTC Therapeutics, Inc.; and Isis Pharmaceuticals, Inc. It serves physicians, hospitals, treatment centers, other providers of medication to patients, retail pharmacies, and government agencies through distributors. The company was founded in 1981 and is based in Cambridge, Massachusetts.

HARLEY-DAVIDSON INC (NYSE:HOG) - Harley-Davidson, Inc. produces and sells heavyweight motorcycles, as well as offers motorcycle parts, accessories, and related services. It operates in two segments, Motorcycles and Related Products, and Financial Services. The Motorcycles and Related Products segment engages in the design, manufacture, and sale of primarily heavyweight touring, custom, and performance motorcycles primarily in North America, Europe, the Middle East, Africa, the Asia/Pacific, and Latin America. It also provides a line of motorcycle parts and accessories, including replacement parts, and mechanical and cosmetic accessories; general merchandise, such as apparel and accessories; and related services. This segment manufactures five families of motorcycles, including Touring, Dyna, Softail, Sportster, and VRSC. It offers its products under the Harley-Davidson, Buell, and Cagiva brand names. The Financial Services segment provides wholesale and retail financing, and insurance and insurance-related programs primarily to the companys dealers and retail customers in the United States and Canada. It engages in financing and servicing wholesale inventory receivables and retail consumer loans primarily for the purchase of motorcycles. This segments wholesale financial services include floorplan and open account financing of motorcycles, and motorcycle parts and accessories to Harley-Davidson and Buell motorcycle dealers. Its retail financial services include installment lending for its new and used motorcycles. The Financial Services segment also provides motorcycle insurance and property/casualty insurance, as well as sells extended service contracts, gap coverage, and debt protection products to motorcycle owners. Harley-Davidson sells its products through independent dealers and distributors. The company was founded in 1903 and is based in Milwaukee, Wisconsin.

METHODE ELECTRONICS INC (NYSE:MEI) - Methode Electronics, Inc. designs and manufactures electro-mechanical devices worldwide. It operates in four segments: Automotive, Interconnect, Power Products, and Other. The Automotive segment supplies electronic and electromechanical devices and related products to automobile original equipment manufacturers directly or through their tiered suppliers, including control switches for electrical power and signals, connectors for electrical devices, integrated control components, switches, and sensors that monitor the operation or status of a component or system, and packaging of electrical components. The Interconnect segment provides various copper and fiber-optic interconnect and interface solutions for the aerospace, appliance, commercial, computer, construction, consumer, material handling, medical, military, mining, networking, storage, and telecommunications markets. Its solutions include connectors, conductive polymer, thick film inks, custom cable assemblies, industrial safety radio remote controls, solid-state field effect interface panels, optical and copper transceivers, PC and express card packaging, and terminators. This segment also designs and installs fiber optic and copper infrastructure systems; and manufactures active and passive optical components. The Power Products segment manufactures braided flexible cables, current-carrying laminated bus devices, custom power-product assemblies, high-current low voltage flexible power cabling systems, and powder coated bus bars used in various markets and applications, including aerospace, computers, industrial and power conversion, insulated gate bipolar transistor solutions, military, telecommunications, and transportation. The Other segment manufactures magnetic torque sensing products. It also provides services for qualification testing and certification, and analysis of electronic and optical components through its laboratories. The company was founded in 1946 and is headquartered in Chicago, Illinois.

CATALYST HEALTH SOLUTIONS IN (NASDAQ:CHSI) - Catalyst Health Solutions, Inc., together with its subsidiaries, operates as a pharmacy benefit management company in the United States. The company provides its clients with plan designs, clinical programs, physician orientation programs, and member education through an electronic point-of-sale system for eligibility verification and plan design information, as well as offers access to rebate arrangements for various branded pharmaceuticals. It operates primarily under the Catalyst Rx brand name. The company provides its clients access to a contracted national network of approximately 63,000 pharmacies. Catalyst Health Solutions, Inc. serves self-insured employers, including state and local governments; managed care organizations; third-party administrators; unions; and individuals. The company was formerly known as HealthExtras, Inc. and changed its name to Catalyst Health Solutions, Inc. in October 2008. Catalyst Health Solutions, Inc. was founded in 1994 and is headquartered in Rockville, Maryland.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641